AXDX

Accelerate Diagnostics
AXDX

Overview Fund Activity
Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

74 hedge funds and large institutions have $18.6M invested in Accelerate Diagnostics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 40 closing their positions.

Holders
74
Holders Change
-32
Holders Change %
-30.19%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
11
Reduced
25
Closed
40
Calls
$34K
Puts
$842K
Net Calls
-$808K
Net Calls Change
-$542K

Top Buyers

1
GAM
1
Griffin Asset Management
New York
$3.95M
2
Citadel Advisors
2
Citadel Advisors
Florida
$1.18M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.29M
4
DKCM
4
Davidson Kempner Capital Management
New York
$252K
5
BAM
5
Belpointe Asset Management
Nevada
$345K

Top Sellers

1
BlackRock
1
BlackRock
New York
$562K
2
Baird Financial Group
2
Baird Financial Group
Wisconsin
$30K
3
Axa
3
Axa
France
$0
4
State Street
4
State Street
Massachusetts
$244K
5
William Blair & Company
5
William Blair & Company
Illinois
$55K
Name Holding Trade Value Shares
Change 		Shares
Change %
Canada Life
101
Canada Life
Manitoba, Canada
– -$3K -198 Closed
ACM
102
Aquatic Capital Management
Illinois
– -$2K -160 Closed
MPWT
103
MassMutual Private Wealth & Trust
Connecticut
– -$2K -137 Closed
CAPTRUST Financial Advisors
104
CAPTRUST Financial Advisors
North Carolina
– -$1K -87 Closed
TFO
105
Tarbox Family Office
California
– -$1K -48 Closed
1 2 3 4
5